Marek's disease virus infection induces widespread differential chromatin marks in inbred chicken lines

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Mitra, Apratim ^a   Luo, Juan ^a   Zhang, Huanming ^b   Cui, Kairong ^c   Zhao, Keji ^c   Song, Jiuzhou ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Bivalent domain; Chromatin signature; Differential marks; Histone modifications; Marek's disease; Thymus

Indexed keywords

HISTONE H3; LYSINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BCL6 GENE; CHICKEN; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; CITED2 GENE; CONTROLLED STUDY; CTLA 4 GENE; EGR1 GENE; EPIGENETICS; GAL GENE; GENE; GENETIC RESISTANCE; GENETIC TRANSCRIPTION; HISTONE MODIFICATION; IGF2BP1 GENE; INBRED STRAIN; MARDIVIRUS; MAREK DISEASE; MX1 GENE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THYMUS; VIRUS LOAD;

ANIMALS; CHICKENS; CHROMATIN; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GALANIN; GENOME; HISTONES; MARDIVIRUS; MAREK DISEASE; METHYLATION; RECEPTOR, GALANIN, TYPE 1; RNA-BINDING PROTEINS; TRANSCRIPTION FACTORS;

AVES; GALLID HERPESVIRUS 2; GALLUS GALLUS;

EID: 84867426796     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-557     Document Type: Article

References (55)

1. Ernst J, Kellis M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat Biotechnol 2010, 28(8):817-825. 10.1038/nbt.1662, 2919626, 20657582.
2. Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011, 473(7345):43-49. 10.1038/nature09906, 3088773, 21441907.
3. Weishaupt H, Sigvardsson M, Attema JL. Epigenetic chromatin states uniquely define the developmental plasticity of murine hematopoietic stem cells. Blood 2010, 115(2):247-256. 10.1182/blood-2009-07-235176, 19887676.
4. Flanagan JM. Host epigenetic modifications by oncogenic viruses. Br J Cancer 2007, 96(2):183-188. 10.1038/sj.bjc.6603516, 2359987, 17179991.
5. Knight JS, Lan K, Subramanian C, Robertson ES. Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human B-cell lines. J Virol 2003, 77(7):4261-4272. 10.1128/JVI.77.7.4261-4272.2003, 150657, 12634383.
6. Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS. The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci U S A 2002, 99(15):10084-10089. 10.1073/pnas.152059399, 126628, 12110730.
7. Osterrieder N, Kamil JP, Schumacher D, Tischer BK, Trapp S. Marek's disease virus: from miasma to model. Nat Rev Microbiol 2006, 4(4):283-294. 10.1038/nrmicro1382, 16541136.
8. Epstein MA, Achong BG, Churchill AE, Biggs PM. Structure and development of the herpes-types virus of Marek's disease. J Natl Cancer Inst 1968, 41(3):805-820.
9. Churchill AE, Payne LN, Chubb RC. Immunization against Marek's disease using a live attenuated virus. Nature 1969, 221(5182):744-747. 10.1038/221744a0, 4304053.
10. Okazaki W, Purchase HG, Burmester BR. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis 1970, 14(2):413-429. 10.2307/1588488, 4913403.
11. Davison F, Nair V. Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?. Expert Rev Vaccines 2005, 4(1):77-88. 10.1586/14760584.4.1.77, 15757475.
12. Gimeno IM. Marek's disease vaccines: a solution for today but a worry for tomorrow?. Vaccine 2008, 26(Suppl 3):C31-C41.
13. Witter RL. Increased virulence of Marek's disease virus field isolates. Avian Dis 1997, 41(1):149-163. 10.2307/1592455, 9087332.
14. Liu HC, Cheng HH, Tirunagaru V, Sofer L, Burnside J. A strategy to identify positional candidate genes conferring Marek's disease resistance by integrating DNA microarrays and genetic mapping. Anim Genet 2001, 32(6):351-359. 10.1046/j.1365-2052.2001.00798.x, 11736805.
15. Liu HC, Kung HJ, Fulton JE, Morgan RW, Cheng HH. Growth hormone interacts with the Marek's disease virus SORF2 protein and is associated with disease resistance in chicken. Proc Natl Acad Sci U S A 2001, 98(16):9203-9208. 10.1073/pnas.161466898, 55398, 11470922.
16. Wain HM, Toye AA, Hughes S, Bumstead N. Targeting of marker loci to chicken chromosome 16 by representational difference analysis. Anim Genet 1998, 29(6):446-452. 10.1046/j.1365-2052.1998.296374.x, 9883506.
17. Smith J, Sadeyen JR, Paton IR, Hocking PM, Salmon N, Fife M, Nair V, Burt DW, Kaiser P. Systems Analysis of Immune Responses in Marek's Disease Virus Infected Chickens Identifies a Gene Involved in Susceptibility and Highlights a Possible Novel Pathogenicity Mechanism. J Virol 2011, 85(21):11146-11158. 10.1128/JVI.05499-11, 3194948, 21865384.
18. McCoy KD, Le Gros G. The role of CTLA-4 in the regulation of T cell immune responses. Immunol Cell Biol 1999, 77(1):1-10. 10.1046/j.1440-1711.1999.00795.x, 10101680.
19. Curran MA, Montalvo W, Yagita H, Allison JP. PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors. Proc Natl Acad Sci U S A 2010, 107(9):4275-4280. 10.1073/pnas.0915174107, 2840093, 20160101.
20. Heidari M, Sarson AJ, Huebner M, Sharif S, Kireev D, Zhou H. Marek's disease virus-induced immunosuppression: array analysis of chicken immune response gene expression profiling. Viral Immunol 2010, 23(3):309-319. 10.1089/vim.2009.0079, 20565294.
21. Fingleton B. Matrix metalloproteinases: roles in cancer and metastasis. Front Biosci 2006, 11:479-491. 10.2741/1811, 16146745.
22. Rath NC, Parcells MS, Xie H, Santin E. Characterization of a spontaneously transformed chicken mononuclear cell line. Vet Immunol Immunopathol 2003, 96(1-2):93-104.
23. Chen C, Li H, Xie Q, Shang H, Ji J, Bai S, Cao Y, Ma Y, Bi Y. Transcriptional profiling of host gene expression in chicken liver tissues infected with oncogenic Marek's disease virus. J Gen Virol 2011, 92:2724-2733. 10.1099/vir.0.034066-0, 21832007.
24. Ioannidis P, Kottaridi C, Dimitriadis E, Courtis N, Mahaira L, Talieri M, Giannopoulos A, Iliadis K, Papaioannou D, Nasioulas G, et al. Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors. Cancer Lett 2004, 209(2):245-250. 10.1016/j.canlet.2003.12.015, 15159028.
25. Ioannidis P, Mahaira L, Papadopoulou A, Teixeira MR, Heim S, Andersen JA, Evangelou E, Dafni U, Pandis N, Trangas T. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas. Int J Cancer 2003, 104(1):54-59. 10.1002/ijc.10794, 12532419.
26. Kato T, Hayama S, Yamabuki T, Ishikawa N, Miyamoto M, Ito T, Tsuchiya E, Kondo S, Nakamura Y, Daigo Y. Increased expression of insulin-like growth factor-II messenger RNA-binding protein 1 is associated with tumor progression in patients with lung cancer. Clin Cancer Res 2007, 13(2 Pt 1):434-442.
27. Ross J, Lemm I, Berberet B. Overexpression of an mRNA-binding protein in human colorectal cancer. Oncogene 2001, 20(45):6544-6550. 10.1038/sj.onc.1204838, 11641779.
28. Su F, Pascal LE, Xiao W, Wang Z. Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53. Oncogene 2010, 29(3):421-431. 10.1038/onc.2009.326, 2809809, 19826414.
29. Berger A, Santic R, Hauser-Kronberger C, Schilling FH, Kogner P, Ratschek M, Gamper A, Jones N, Sperl W, Kofler B. Galanin and galanin receptors in human cancers. Neuropeptides 2005, 39(3):353-359. 10.1016/j.npep.2004.12.016, 15944034.
30. Rauch I, Kofler B. The galanin system in cancer. EXS 2010, 102:223-241.
31. Bernstein BE, Mikkelsen TS, Xie X, Kamal M, Huebert DJ, Cuff J, Fry B, Meissner A, Wernig M, Plath K, et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 2006, 125(2):315-326. 10.1016/j.cell.2006.02.041, 16630819.
32. Sanz LA, Chamberlain S, Sabourin JC, Henckel A, Magnuson T, Hugnot JP, Feil R, Arnaud P. A mono-allelic bivalent chromatin domain controls tissue-specific imprinting at Grb10. EMBO J 2008, 27(19):2523-2532. 10.1038/emboj.2008.142, 2567399, 18650936.
33. Rodriguez J, Munoz M, Vives L, Frangou CG, Groudine M, Peinado MA. Bivalent domains enforce transcriptional memory of DNA methylated genes in cancer cells. Proc Natl Acad Sci U S A 2008, 105(50):19809-19814. 10.1073/pnas.0810133105, 2596747, 19060200.
34. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
35. da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37(1):1-13. 10.1093/nar/gkn923, 2615629, 19033363.
36. Chan HM, La Thangue NB. p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J Cell Sci 2001, 114(Pt 13):2363-2373.
37. Thiel G, Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J Cell Physiol 2002, 193(3):287-292. 10.1002/jcp.10178, 12384981.
38. Scharnhorst V, Menke AL, Attema J, Haneveld JK, Riteco N, van Steenbrugge GJ, van der Eb AJ, Jochemsen AG. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity. Oncogene 2000, 19(6):791-800. 10.1038/sj.onc.1203390, 10698497.
39. Huang RP, Liu C, Fan Y, Mercola D, Adamson ED. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 1995, 55(21):5054-5062.
40. Buscaglia C, Calnek BW. Maintenance of Marek's disease herpesvirus latency in vitro by a factor found in conditioned medium. J Gen Virol 1988, 69(Pt 11):2809-2818.
41. Deng X, Li X, Shen Y, Qiu Y, Shi Z, Shao D, Jin Y, Chen H, Ding C, Li L, et al. The Meq oncoprotein of Marek's disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities. Virol J 2010, 7:348. 10.1186/1743-422X-7-348, 2999606, 21110861.
42. Wu Z-Z, Sun N-K, Chao CCK. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis. J Cell Physiol 2011, 226(9):2415-2428. 10.1002/jcp.22589, 21660965.
43. Phan RT, Dalla-Favera R. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells. Nature 2004, 432(7017):635-639. 10.1038/nature03147, 15577913.
44. Schat KA, Chen CL, Calnek BW, Char D. Transformation of T-lymphocyte subsets by Marek's disease herpesvirus. J Virol 1991, 65(3):1408-1413. 239919, 1847460.
45. Yu Y, Luo J, Mitra A, Chang S, Tian F, Zhang H, Yuan P, Zhou H, Song J. Temporal Transcriptome Changes Induced by MDV in Marek's Disease-Resistant and -Susceptible Inbred Chickens. BMC Genomics 2011, 12(1):501. 10.1186/1471-2164-12-501, 3269463, 21992110.
46. Morimura T, Ohashi K, Kon Y, Hattori M, Sugimoto C, Onuma M. Apoptosis and CD8-down-regulation in the thymus of chickens infected with Marek's disease virus. Arch Virol 1996, 141(11):2243-2249. 10.1007/BF01718230, 8973538.
47. Luo J, Mitra A, Tian F, Chang S, Zhang H, Cui K, Yu Y, Zhao K, Song J. Histone Methylation Analysis and Pathway Predictions in Chickens after MDV Infection. PLoS One 2012, 7(7):e41849. 10.1371/journal.pone.0041849, 3406056, 22848633.
48. Yunis R, Jarosinski KW, Schat KA. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains. Virology 2004, 328(1):142-150. 10.1016/j.virol.2004.07.017, 15380365.
49. Zehner ZE, Paterson BM. Characterization of the chicken vimentin gene: single copy gene producing multiple mRNAs. Proc Natl Acad Sci U S A 1983, 80(4):911-915. 10.1073/pnas.80.4.911, 393497, 6573660.
50. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129(4):823-837. 10.1016/j.cell.2007.05.009, 17512414.
51. Li X, Chiang HI, Zhu J, Dowd SE, Zhou H. Characterization of a newly developed chicken 44K Agilent microarray. BMC Genomics 2008, 9:60. 10.1186/1471-2164-9-60, 2262898, 18237426.
52. Zang C, Schones DE, Zeng C, Cui K, Zhao K, Peng W. A clustering approach for identification of enriched domains from histone modification ChIP-Seq data. Bioinformatics 2009, 25(15):1952-1958. 10.1093/bioinformatics/btp340, 2732366, 19505939.
53. Fujita PA, Rhead B, Zweig AS, Hinrichs AS, Karolchik D, Cline MS, Goldman M, Barber GP, Clawson H, Coelho A, et al. he UCSC Genome Browser database: update 2011. Nucleic Acids Res 2010, 39(Database issue):D876-D882. 3242726, 20959295.
54. Anders S, Huber W. Differential expression analysis for sequence count data. Genome Biol 2010, 11(10):R106. 10.1186/gb-2010-11-10-r106, 3218662, 20979621.
55. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J Royal Stat Soc Series B (Methodological) 1995, 57(1):289-300.